Nothing Special   »   [go: up one dir, main page]

SG11202100172XA - Antibody molecules that bind cd137 and ox40 - Google Patents

Antibody molecules that bind cd137 and ox40

Info

Publication number
SG11202100172XA
SG11202100172XA SG11202100172XA SG11202100172XA SG11202100172XA SG 11202100172X A SG11202100172X A SG 11202100172XA SG 11202100172X A SG11202100172X A SG 11202100172XA SG 11202100172X A SG11202100172X A SG 11202100172XA SG 11202100172X A SG11202100172X A SG 11202100172XA
Authority
SG
Singapore
Prior art keywords
bind
antibody molecules
antibody
molecules
Prior art date
Application number
SG11202100172XA
Inventor
Mihriban Tuna
Miguel Gaspar
Michelle Morrow
Edmund Poon
Original Assignee
F Star Beta Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1811407.4A external-priority patent/GB201811407D0/en
Priority claimed from GBGB1818281.6A external-priority patent/GB201818281D0/en
Priority claimed from GBGB1902598.0A external-priority patent/GB201902598D0/en
Application filed by F Star Beta Ltd filed Critical F Star Beta Ltd
Publication of SG11202100172XA publication Critical patent/SG11202100172XA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2818—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD28 or CD152
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2827—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against B7 molecules, e.g. CD80, CD86
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2878—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/32—Immunoglobulins specific features characterized by aspects of specificity or valency specific for a neo-epitope on a complex, e.g. antibody-antigen or ligand-receptor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/64—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising a combination of variable region and constant region components
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/75—Agonist effect on antigen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11202100172XA 2018-07-12 2019-07-12 Antibody molecules that bind cd137 and ox40 SG11202100172XA (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB1811407.4A GB201811407D0 (en) 2018-07-12 2018-07-12 Antibody molecules that bind CD137 and OX40
GBGB1818281.6A GB201818281D0 (en) 2018-11-09 2018-11-09 Antibody molecules that bind CD137 and OX40
GBGB1902598.0A GB201902598D0 (en) 2019-02-26 2019-02-26 Antibody molecules that bind cd137 and ox40
PCT/EP2019/068796 WO2020011966A1 (en) 2018-07-12 2019-07-12 Antibody molecules that bind cd137 and ox40

Publications (1)

Publication Number Publication Date
SG11202100172XA true SG11202100172XA (en) 2021-02-25

Family

ID=67383740

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202100172XA SG11202100172XA (en) 2018-07-12 2019-07-12 Antibody molecules that bind cd137 and ox40

Country Status (13)

Country Link
US (1) US20220048996A1 (en)
EP (1) EP3820898A1 (en)
JP (2) JP7397055B2 (en)
KR (1) KR20210031479A (en)
CN (1) CN112424229B (en)
AU (1) AU2019301206A1 (en)
BR (1) BR112021000282A2 (en)
CA (1) CA3106048A1 (en)
IL (1) IL280002A (en)
MX (1) MX2021000399A (en)
SG (1) SG11202100172XA (en)
TW (1) TWI847989B (en)
WO (1) WO2020011966A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201612520D0 (en) 2016-07-19 2016-08-31 F-Star Beta Ltd Binding molecules
US11548948B2 (en) 2017-12-19 2023-01-10 F-Star Therapeutics Limited FC binding fragments comprising a PD-L1 antigen-binding site
CN112585165A (en) 2018-04-25 2021-03-30 普罗米修斯生物科学公司 Optimized anti-TL 1A antibodies
GB201811408D0 (en) 2018-07-12 2018-08-29 F Star Beta Ltd CD137 Binding Molecules
IL292419A (en) 2019-10-24 2022-06-01 Prometheus Biosciences Inc Humanized antibodies to tnf-like ligand 1a (tl1a) and uses thereof
US20240150483A1 (en) * 2021-02-17 2024-05-09 Aptevo Research And Development Llc COMPOSITIONS COMPRISING 4-1BB and OX40 BINDING PROTEINS AND METHODS OF USE
KR20230171465A (en) * 2021-04-22 2023-12-20 아스텔라스세이야쿠 가부시키가이샤 Anti-CLDN4-anti-CD137 bispecific antibody
CN114478771B (en) * 2021-12-14 2024-06-25 英诺湖医药(杭州)有限公司 OX40 antibodies and medical uses thereof
WO2024040195A1 (en) 2022-08-17 2024-02-22 Capstan Therapeutics, Inc. Conditioning for in vivo immune cell engineering

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JPS61134325A (en) 1984-12-04 1986-06-21 Teijin Ltd Expression of hybrid antibody gene
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US7288638B2 (en) 2003-10-10 2007-10-30 Bristol-Myers Squibb Company Fully human antibodies against human 4-1BB
MX2007008118A (en) 2005-01-05 2008-03-13 F Star Biotech Forsch & Entw Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions.
CA3151350A1 (en) 2005-05-09 2006-11-16 E. R. Squibb & Sons, L.L.C. Human monoclonal antibodies to programmed death 1 (pd-1) and methods for treating cancer using anti-pd-1 antibodies alone or in combination with other immunotherapeutics
GB0624500D0 (en) * 2006-12-07 2007-01-17 Istituto Superiore Di Sanito A novel passive vaccine for candida infections
WO2009079335A1 (en) 2007-12-14 2009-06-25 Medarex, Inc. Binding molecules to the human ox40 receptor
EP2113255A1 (en) 2008-05-02 2009-11-04 f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H. Cytotoxic immunoglobulin
DK4209510T5 (en) 2008-12-09 2024-07-22 Hoffmann La Roche ANTI-PD-L1 ANTIBODIES AND THEIR USE IN PROMOTING T CELL FUNCTION
EP2614082B1 (en) 2010-09-09 2018-10-03 Pfizer Inc 4-1bb binding molecules
CA2874083C (en) * 2014-12-05 2024-01-02 Universite Laval Tdp-43-binding polypeptides useful for the treatment of neurodegenerative diseases
IL255767B2 (en) * 2015-05-21 2024-04-01 Alligator Bioscience Ab Novel polypeptides
GB201519481D0 (en) * 2015-11-04 2015-12-16 Cancer Rec Tech Ltd Immunomodulatory antibodies

Also Published As

Publication number Publication date
TWI847989B (en) 2024-07-11
CN112424229A (en) 2021-02-26
WO2020011966A1 (en) 2020-01-16
KR20210031479A (en) 2021-03-19
CA3106048A1 (en) 2020-01-16
EP3820898A1 (en) 2021-05-19
JP7397055B2 (en) 2023-12-12
MX2021000399A (en) 2021-05-27
TW202019963A (en) 2020-06-01
AU2019301206A1 (en) 2021-03-04
JP2024019415A (en) 2024-02-09
BR112021000282A2 (en) 2021-04-06
JP2021524267A (en) 2021-09-13
CN112424229B (en) 2024-07-30
US20220048996A1 (en) 2022-02-17
IL280002A (en) 2021-03-01

Similar Documents

Publication Publication Date Title
IL280002A (en) Antibody molecules that bind cd137 and ox40
HUS2300011I1 (en) Anti-bcma antibodies, bispecific antigen binding molecules that bind bcma and cd3, and uses thereof
IL275510A (en) Ror1-specific antigen binding molecules
IL287565A (en) Antibodies that bind cd39 and uses thereof
IL280004A (en) Antibody molecules that bind pd-l1 and cd137
IL259082A (en) Anti-il1rap antibodies, bispecific antigen binding molecules that bind il1rap and cd3, and uses thereof
ZA201700528B (en) Anti-ctla4 monoclonal antibody or antigen binding fragment thereof, medicinal composition and use
IL271696A (en) Agonist antibodies that bind human cd137 and uses thereof
SG10201912366YA (en) Anti-cd3 antibody and molecules comprising the antibody
GB201811410D0 (en) OX40 Binding molecules
GB201811403D0 (en) Antibody molecules
IL292799A (en) Anti-siglec-9 antibody molecules
HK1255409A1 (en) Antibody binding agents that bind acinetobacter and uses thereof
GB201818281D0 (en) Antibody molecules that bind CD137 and OX40
GB201811407D0 (en) Antibody molecules that bind CD137 and OX40
GB201902598D0 (en) Antibody molecules that bind cd137 and ox40
GB201820446D0 (en) Antigen binding molecules that bind light
GB201818283D0 (en) Antibody molecules that bind PD-L1 and CD137
GB201811405D0 (en) Antibody molecules that bind PD-L1 and CD137
GB201902594D0 (en) Antibody molecules that bind pd-l1 and cd137
TWI861005B (en) Antibody molecules that bind pd-l1 and cd137
GB201808589D0 (en) Single domain antibodies that bind CD137